Trial Details
COMPLETEDBasic Information
| Clinical ID | c2291 |
|---|---|
| Identifier | NCT03723447 |
| Trial Title | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Pain, Postoperative|Crohn Disease|Inflammatory Bowel Diseases|Colorectal Cancer|Gastrointestinal Cancer|Gastrointestinal Disease|Digestive System Disease|Pain|Pain, Neuropathic|Intestinal Disease |
| Interventions | DRUG: Liposomal bupivacaine|DRUG: Bupivacaine/epinephrine/dexamethasone |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2018-10-23 |
|---|---|
| Primary Completion Date | 2019-10-29 |
| Completion Date | 2019-10-29 |